Pathological response and prognostic factors of neoadjuvant PD-1 blockade combined with chemotherapy in resectable oesophageal squamous cell carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Honglei,Wang

第一单位： Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

作者： Honglei,Wang ^[1] ; Zeying,Jiang ^[1] ; Qihua,Wang ^[1] ; Tong,Wu ^[1] ; Fangzhou,Guo ^[1] ; Zhengyuan,Xu ^[1] ; Weixiong,Yang ^[2] ; Shicong,Yang ^[1] ; Shiting,Feng ^[3] ; Xiaoyan,Wang ^[4] ; Shuling,Chen ^[5] ; Chao,Cheng ^[6] ; Wenfang,Chen ^[7]

作者单位： Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. ^[1] Department of Thoracic Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. ^[2] Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. ^[3] Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. ^[4] Division of Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. ^[5] Department of Thoracic Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address: chengch3@mail.sysu.edu.cn. ^[6] Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address: chwfang@mail.sysu.edu.cn. ^[7]

关键词 Esophageal squamous cell carcinoma Neoadjuvant immunotherapy PD-1 inhibitor Pathological response Recurrence